» Articles » PMID: 32503840

Characterization of SETD3 Methyltransferase-mediated Protein Methionine Methylation

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2020 Jun 7
PMID 32503840
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Most characterized protein methylation events encompass arginine and lysine -methylation, and only a few cases of protein methionine thiomethylation have been reported. Newly discovered oncohistone mutations include lysine-to-methionine substitutions at positions 27 and 36 of histone H3.3. In these instances, the methionine substitution localizes to the active-site pocket of the corresponding histone lysine methyltransferase, thereby inhibiting the respective transmethylation activity. SET domain-containing 3 (SETD3) is a protein ( actin) histidine methyltransferase. Here, we generated an actin variant in which the histidine target of SETD3 was substituted with methionine. As for previously characterized histone SET domain proteins, the methionine substitution substantially (76-fold) increased binding affinity for SETD3 and inhibited SETD3 activity on histidine. Unexpectedly, SETD3 was active on the substituted methionine, generating -methylmethionine in the context of actin peptide. The ternary structure of SETD3 in complex with the methionine-containing actin peptide at 1.9 Å resolution revealed that the hydrophobic thioether side chain is packed by the aromatic rings of Tyr and Trp, as well as the hydrocarbon side chain of Ile Our results suggest that placing methionine properly in the active site-within close proximity to and in line with the incoming methyl group of SAM-would allow some SET domain proteins to selectively methylate methionine in proteins.

Citing Articles

Examining prestructured β-actin peptides as substrates of histidine methyltransferase SETD3.

Maas M, Bilgin N, Moesgaard L, Hintzen J, Drozak A, Drozak J Sci Rep. 2024; 14(1):26439.

PMID: 39488591 PMC: 11531485. DOI: 10.1038/s41598-024-76562-z.


A global view of the human post-translational modification landscape.

Kitamura N, Galligan J Biochem J. 2023; 480(16):1241-1265.

PMID: 37610048 PMC: 10586784. DOI: 10.1042/BCJ20220251.


Structural basis for MTA1c-mediated DNA N6-adenine methylation.

Chen J, Hu R, Chen Y, Lin X, Xiang W, Chen H Nat Commun. 2022; 13(1):3257.

PMID: 35672411 PMC: 9174199. DOI: 10.1038/s41467-022-31060-6.


Histidine methyltransferase SETD3 methylates structurally diverse histidine mimics in actin.

Hintzen J, Ma H, Deng H, Witecka A, Andersen S, Drozak J Protein Sci. 2022; 31(5):e4305.

PMID: 35481649 PMC: 9004244. DOI: 10.1002/pro.4305.


Computational Study of Methionine Methylation Process Catalyzed by SETD3.

Zhao Y, Deng H, Rahman A, Xu X, Qian P, Guo H Interdiscip Sci. 2022; 14(4):929-936.

PMID: 35419695 DOI: 10.1007/s12539-022-00516-0.


References
1.
Shan C, Wang J, Xu K, Chen H, Yue J, Andrews S . A histone H3K9M mutation traps histone methyltransferase Clr4 to prevent heterochromatin spreading. Elife. 2016; 5. PMC: 5030085. DOI: 10.7554/eLife.17903. View

2.
Koh-Stenta X, Poulsen A, Li R, Wee J, Kwek P, Chew S . Discovery and characterisation of the automethylation properties of PRDM9. Biochem J. 2017; 474(6):971-982. DOI: 10.1042/BCJ20161067. View

3.
Lowe B, Maxham L, Hamey J, Wilkins M, Partridge J . Histone H3 Mutations: An Updated View of Their Role in Chromatin Deregulation and Cancer. Cancers (Basel). 2019; 11(5). PMC: 6562757. DOI: 10.3390/cancers11050660. View

4.
Tolsma T, Hansen J . Post-translational modifications and chromatin dynamics. Essays Biochem. 2019; 63(1):89-96. DOI: 10.1042/EBC20180067. View

5.
Marinaki A, Arenas-Hernandez M . Reducing risk in thiopurine therapy. Xenobiotica. 2019; 50(1):101-109. DOI: 10.1080/00498254.2019.1688424. View